Intra Cellular Therapies shares owned by T. Rowe Price Associates
Quarter-by-quarter ownership of Intra Cellular Therapies (ITCI) shares owned by T. Rowe Price Associates
from 13F filings
Historical chart of T. Rowe Price Associates investment in Intra Cellular Therapies
Tip: Access up to 7 years of quarterly data
All positions including Intra Cellular Therapies held by T. Rowe Price Associates consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Intra Cellular Therapies by T. Rowe Price Associates
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-12-31 | $49M | 590k | 83.52 |
| 2024-09-30 | $76M | 1.0M | 73.17 |
| 2024-06-30 | $98M | 1.4M | 68.49 |
| 2024-03-31 | $83M | 1.2M | 69.20 |
| 2023-12-31 | $90M | 1.3M | 71.62 |
| 2023-09-30 | $34M | 657k | 52.09 |
| 2023-06-30 | $42M | 656k | 63.32 |
| 2023-03-31 | $30M | 544k | 54.15 |
| 2022-12-31 | $28M | 532k | 52.92 |
| 2022-03-31 | $2.4M | 40k | 61.18 |
| 2021-12-31 | $1.9M | 36k | 52.34 |
| 2021-09-30 | $1.5M | 41k | 37.29 |
| 2021-06-30 | $1.5M | 36k | 40.81 |
| 2021-03-31 | $1.4M | 40k | 33.93 |
| 2020-12-31 | $1.0M | 32k | 31.79 |
| 2020-09-30 | $8.0M | 313k | 25.66 |
| 2020-06-30 | $25M | 962k | 25.67 |
| 2020-03-31 | $23M | 1.5M | 15.37 |
| 2019-12-31 | $44M | 1.3M | 34.31 |
| 2019-09-30 | $542k | 73k | 7.47 |
| 2019-06-30 | $4.6M | 356k | 12.98 |
| 2019-03-31 | $4.3M | 356k | 12.18 |
| 2018-12-31 | $4.0M | 351k | 11.39 |
| 2018-09-30 | $9.6M | 441k | 21.70 |
| 2018-06-30 | $15M | 841k | 17.67 |
| 2018-03-31 | $24M | 1.1M | 21.05 |
| 2017-12-31 | $354k | 24k | 14.49 |
| 2017-06-30 | $176k | 14k | 12.45 |
| 2017-03-31 | $7.9M | 483k | 16.25 |
| 2016-12-31 | $7.8M | 517k | 15.09 |
| 2016-09-30 | $8.6M | 564k | 15.24 |
| 2016-06-30 | $373k | 9.6k | 38.83 |
| 2016-03-31 | $266k | 9.6k | 27.80 |